Clinical Trial Update: Lamictal TM, Haloperidol Decanoate in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial of Lamictal and haloperidol decanoate for schizophrenia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• HALOPERIDOL DECANOATE (Haloperidol decanoate)
• LAMICTAL (LAMOTRIGINE)

Snippet

Sponsor: Central Mental Clinic for Outpatients of Baku City | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED